Collateral for a security interest recorded Dec 19, 2012 (Biopharma Secured Debt Fund II Holdings Cayman LP).
Term ends Oct 16, 2030 · High confidence
20-year base term ends Apr 29, 2030
Filed Apr 29, 2010 as application 12/769,885 · Granted Oct 30, 2012
Base term plus 170 days of patent term adjustment (USPTO delay)
Today
2010
2030
Clock starts
Apr 29, 2010
Apr 29, 2010
Term ends
Oct 16, 2030
Oct 16, 2030
Granted
Oct 30, 2012
Oct 30, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
170
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
29
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 170 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 29, 2010, when this application, 12/769,885, was filed | Apr 29, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +170 days, USPTO patent term adjustment record | Oct 16, 2030 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 16, 2030 | High confidence |
This family
| US 8,298,554 | this patent Oct 2030 | Oct 2030 |
| US 8,445,003 | In force Feb 2030 | Feb 2030 |
| US 8,454,994 | In force Apr 2030 | Apr 2030 |
| US 8,501,225 | In force Feb 2030 | Feb 2030 |
| US 8,445,013 | In force Feb 2030 | Feb 2030 |
| US 8,613,945 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,663,662 | Lapsed on the fee record Mar 2026 | Mar 2026 |
| US 8,623,406 | Lapsed on the fee record Jan 2026 | Jan 2026 |
8 of 29 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 19, 2010 Reel 24410, frame 329 | Manku, Mehar | Amarin Corporation PLC. | Assignment of Assignor's Interest |
| Jun 4, 2010 Reel 24485, frame 334 | Amarin Corporation PLC | Amarin Pharma, Inc. | Assignment of Assignor's Interest |
| May 31, 2012 Reel 28295, frame 491 | Amarin Pharma Inc. | Amarin Pharmaceuticals Ireland Limited | Assignment of Assignor's Interest |
| Dec 19, 2012 Reel 29499, frame 87 | Amarin Pharmaceuticals Ireland Limited | Biopharma Secured Debt Fund II Holdings Cayman LP | Security Agreement |
| Dec 20, 2017 Reel 44956, frame 395 | Biopharma Secured Debt Fund II Holdings Cayman LP | Cppib Credit Europe S.À R.L. | Patent Security Assignment and Assumption Agreement |
| Dec 21, 2017 Reel 44938, frame 257 | Amarin Pharmaceuticals Ireland Limited | Cppib Credit Europe S.À R.L. | Security Interest |
| Nov 19, 2020 Reel 54484, frame 552 | Cppib Credit Europe S.À R.L. | Amarin Pharmaceuticals Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2030
Term ends Oct 16, 2030. No further fees fall due before then
Note
The 170 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
266
later US patents cite this one
That is top 5% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.